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Retinoic acid-treated mesenchyme cells of the budding ascidian Polyandrocarpa misakiensis acquire an organizer activity
to induce a secondary body axis when implanted into developing buds. We identified several different mRNAs that were
upregulated in the mesenchyme cells after retinoic acid treatment. We isolated a cDNA clone corresponding to one of these
mRNAs. The C-terminal region of the predicted protein product is homologous to the catalytic domain of serine proteases
that belong to the trypsin family. The N-terminal region contains several types of protein–protein interaction domains. We
therefore named this protein tunicate retinoic acid-inducible modular protease (TRAMP). Expression of the TRAMP mRNA
in mesenchyme cells during budding and its upregulation by retinoic acid were demonstrated by reverse transcription-PCR
and in situ hybridization. A glutathione S-transferase–TRAMP fusion protein showed a protease activity with trypsin-like
substrate specificity and stimulated proliferation of the cell line established in this species. © 1999 Academic PressKey Words: ascidian; budding; transdifferentiation; retinoic acid; protease.
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Retinoic acid (RA) induces malformation in various de-
velopmental fields of vertebrate embryos and regenerating
organs. Similar effects were also observed in embryos (Hol-
land and Holland, 1996; Katsuyama et al., 1995) and asexual
buds (Hara et al., 1992) of protochordates. The growing bud
f the ascidian Polyandrocarpa misakiensis is formed as an
outgrowth of the parental body wall (Fig. 1A). After separa-
tion from the parent, the atrial epithelium of the most
proximal region dedifferentiates, enters the cell cycle, and
redifferentiates into the gut (Figs. 1B and 1C). The pharynx,
neural gland, and some other tissues also arise from the
atrial epithelium through transdifferentiation (Fig. 1D;
Kawamura and Nakauchi, 1991; Fujiwara and Kawamura,
1992; Kawamura and Fujiwara, 1994). When an RA-
containing bead was implanted in the mesenchymal space
of the distal region, an ectopic gut was formed near the
bead, resulting in a complete duplication of the entire body
Sequence data from this article have been deposited with the
EMBL/GenBank Data Libraries under Acccession Nos. AB030007
and AB030008.
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38xis in the developing bud (Hara et al., 1992). The activity of
ldehyde dehydrogenase, which is a potential RA synthase,
as observed in the most proximal region of the normally
eveloping buds (Kawamura et al., 1993; Harafuji et al.,
1996). The amount of retinal was greatly reduced during
bud development (Kawamura et al., 1993). These results
uggest that RA is an endogenous determinant directing the
nitiation of transdifferentiation of the atrial epithelium
Kawamura and Fujiwara, 1995a).
Explants of the atrial epithelium stably express specific
ntigen under culture conditions. RA does not affect the
ntigen expression, suggesting that it does not induce
ransdifferentiation directly. Instead, the conditioned me-
ium of the RA-treated mesenchyme cells induced dediffer-
ntiation of atrial epithelium explants (K.K., unpublished
ata). The RA-treated mesenchyme cells can induce dupli-
ation of the anteroposterior axis in the developing bud,
hen implanted in the distal region (K. Hara, personal
ommunication). A retinoic acid receptor (RAR) and a
etinoid X receptor (RXR) are expressed in the mesenchyme
ells during budding (Hisata et al., 1998; Kamimura et al.,
submitted for publication), suggesting that it is mesen-
chyme cells that express one or more secreted trans-
differentiation-inducing factors in response to RA (Kawa-
mura and Fujiwara, 1995a).
Using the differential display technique, we identified
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39Retinoic Acid-Inducible Protease in Ascidiansseveral different cDNA fragments that are more abundant
in the RA-treated mesenchyme cells than in the untreated
cells. One of these cDNAs encodes a polypeptide that
contains several types of protein–protein interaction do-
mains in the long N-terminal region and a trypsin-like
protease domain in the C-terminal region. This protein,
named tunicate retinoic acid-inducible modular protease
TRAMP), also contains a putative N-terminal signal se-
uence, suggesting that it is a secreted protein. Here we
how that TRAMP is inducible by RA and upregulated
uring budding. A recombinant TRAMP catalytic domain
as a protease activity with trypsin-type substrate specific-
ty and can stimulate proliferation of the cell line estab-
ished from the atrial epithelium.
MATERIALS AND METHODS
Animals. P. misakiensis was cultured on glass slides in the
boxes settled in the Uranouch Inlet near Usa Marine Biological
Institute of Kochi University.
Differential display. The mesenchyme cells isolated from
dult individuals were treated with 2 mM 13-cis-RA at 20°C for 4 h.
After RA was washed off, the cells were incubated in sterilized sea
water at 20°C for 0, 2, or 6 h. RNA samples, extracted from these
cells, were used for cDNA synthesis after DNase I treatment. The
FIG. 1. Bud development of Polyandrocarpa misakiensis. (A) T
separates from the parent and starts cell differentiation and mo
dedifferentiates and enters the cell cycle (arrow). (C) The atrial e
redifferentiates into the gut. (D) The pharyngeal primordium is alsfluorescent differential display was performed according to the
protocol described by Ito et al. (1994) and Ito and Sakaki (1997).
Copyright © 1999 by Academic Press. All rightReverse transcription was performed using the anchor primer
(59-GT15X-39) (X is A, C, or G). PCR was performed using the anchor
primer and a fluorescein isothiocyanate-conjugated arbitrary deca-
nucleotide primer. PCR products were separated in 6% polyacryl-
amide gels containing 8 M urea and visualized by FluorImager SI
(Molecular Dynamics, Tokyo, Japan). Bands of interest were ex-
cised from the gels, and DNA was reamplified by PCR. Products of
the second PCR were cloned into pCRII (Invitrogen, San Diego,
CA).
Isolation and characterization of cDNA clones. A lgt11
DNA library constructed from poly(A)1 RNA of a colony of P.
isakiensis (Shimada et al., 1995) was screened with 32P-labeled
RAMP-specific probe. The sequences of the cDNA inserts were
etermined using a 373A automatic sequence analyzing system
Perkin-Elmer, Emeryville, USA).
Reverse transcription-PCR (RT-PCR) and in situ hybridization.
NA extraction and cDNA synthesis were performed as described
bove, except that the primer for reverse transcription was a mixture
f the three types of anchor primers. PCR was performed using the
ollowing primer combinations: 59-GCAGACACAGTGGATGG-39
and 59-TTTTTTACTAGTTTATGCGTCGAA-39 (for TRAMP) and
59-CCAGTTCAAAAAACACTCAG-39 and 59-TCTGGCCTTATT-
CCATCCT-39 [for glycerin-3-phosphate dehydrogenase (G3PDH)].
PCR products were examined by ethidium bromide staining or
hybridization using specific DNA probes, as described in Hisata et al.
(1998). In situ hybridization was carried out as described by Hisata et
al. (1998).
owing bud is an outgrowth of the parental body wall. The bud
genesis. (B) The atrial epithelium in the most proximal region
lium of this region invaginates into the mesenchymal space and
med as foldings of the atrial epithelium.he gr
rphoGlutathione S-transferase fusion protein. A TRAMP cDNA
fragment corresponding to the catalytic domain was amplified by
s of reproduction in any form reserved.
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40 Ohashi et al.PCR using primers 59-ATAGTCGGTGGTAGCGGAACT-39 and
59-TTATGCGTCGAAATCGAGTCC-39. The PCR fragment was
inserted into the pGEX-4T-2 (Pharmacia, Piscataway, NJ). Purified
glutathione S-transferase–TRAMP (GST–TRAMP) was dissolved in
0 mM sodium phosphate buffer (pH 7.0), containing 0.1 mM
ynthetic substrates conjugated with methylcoumarylamide
MCA). The substrates used were N-t-butoxy-carbonyl-Gln-Ala-
Arg-MCA (Boc-Gln-Ala-Arg-MCA) for trypsin activity and Boc-Val-
Leu-Lys-MCA for plasmin activity (Peptide Laboratories, Osaka,
Japan). After enzymatic reaction at 35°C for 1 h, the solutions were
examined with a high-performance liquid chromatography (HPLC)
system (Jasco 801SC, 880-02, 880-PU, and 875-UV, Japan Spectro-
scopic Co., Tokyo, Japan). A Cosmosil 5C18 column (Nacalai
esque, Kyoto, Japan) was used for reverse-phase HPLC. The
olumn was eluted with a solution containing 70% methanol and
.1% acetic acid at a flow rate of 1 ml/min. 7-Amino-4-
ethylcoumarin (AMC), the product of the proteolytic reactions,
as detected with excitation at 380 nm and emission at 460 nm,
sing a spectrofluorometer (821-FP, Japan Spectroscopic Co., To-
yo, Japan). The concentration of AMC was logarithmically linear
o fluorescence intensity, ranging at least from 50 nM to 20 mM
(not shown). To make a standard of enzymatic activity, pancreatic
trypsin (Merck, Darmstadt, Germany) was used at concentrations
from 20 ng/ml to 1 mg/ml. In the present study, one unit indicates
he activity to release 0.1 mM AMC/1 h at 35°C.
Bioassays. The cell line established from the atrial epithelium
(Kawamura and Fujiwara, 1995b) was suspended in the tunicate cell
culture medium (TCM) at a concentration of 1.5 3 105 cells/ml. As
escribed in Kawamura and Fujiwara (1995b), the TCM consisted of
epes-buffered Millipore-filtered seawater and Dulbecco’s modi-
ed Eagle’s medium, but it lacked fetal bovine serum (FBS), as FBS
s known to have a variety of proteolytic activities including
rypsin. The cells were continuously treated with various concen-
rations of the recombinant TRAMP or the trypsin for 4 days.
RESULTS
Isolation of cDNAs for RA-Inducible Transcripts
by Differential Display
The differential display method was used to identify
genes that are upregulated upon treatment with RA in the
mesenchyme cells of the ascidian P. misakiensis. Among
bout 6000 bands obtained with 90 different arbitrary PCR
rimers, 4 bands were stronger in the case of treated cells
nd weaker or completely missing in the case of untreated
ells (one of these bands, termed 2-2, is shown in Fig. 2A).
sing a combination of specific primers, expression of the
-2 mRNA in the RA-treated mesenchyme cells was exam-
ned by RT-PCR (Fig. 2B). The expression pattern coincides
ith that obtained by the differential display analysis
compare Figs. 2A and 2B). We therefore conclude that this
DNA is of an RA-inducible gene.
Using the 2-2 cDNA as a probe, we obtained two cDNA
lones. The longer clone is 2803 bp in length and the
ongest open reading frame encodes a polypeptide of 868
mino acids. The nucleotide sequence around the putative
tart codon matches the consensus for the eukaryotic
ranslation initiation site (Kozak, 1989). The size of the
ranscripts deduced from Northern blot analysis is about 3
Copyright © 1999 by Academic Press. All rightb (data not shown). These results suggest that we obtained
cDNA clone covering the entire translated region.
Characterization of the Serine Protease cDNA
Sequence
Because of the modular structure described below, and
schematically drawn in Fig. 3A, we named this protein,
TRAMP. An N-terminal signal sequence suggests that the
protein is secreted by proteolytic cleavage (Fig. 3A; Perlman
and Halvorson, 1983). The N-terminal region of TRAMP
contains several distinct domains (Fig. 3A). Two macro-
phage scavenger receptor cysteine-rich (SRCR) motifs and
three low-density lipoprotein receptor class A (LDLRA)
domains were found (Figs. 3B and 3C). Both types of
domains contain six cysteine residues that form three
disulfide bonds. Between the second and the third LDLRA
domains, there is a sequence similar to the activation
peptide located in the N-terminal region of plasminogen
and plasminogen-related gene B (Fig. 3D). The protease
domain is located in the C-terminus (Fig. 3E). This domain
shows all the sequence features conserved among the serine
proteases that belong to the trypsin family (Fig. 3E; Hartley,
1970; Furie et al., 1982). Many serine proteases are activated
y proteolytic cleavage at a specific site between the
-terminal regulatory chain and the C-terminal catalytic
omain (Neurath, 1957; Furie and Furie, 1988). Arg623 just
pstream of the conserved Ile-Val-Gly-Gly sequence at the
-terminal region of the catalytic domain suggests that
RAMP is activated by a protease that has trypsin-like
ubstrate specificity (Fig. 3A).
TRAMP mRNA Expression during Budding
FIG. 2. Differential display and RT-PCR analysis showing RA
inducibility of the 2-2 transcripts. Mesenchyme cells were treated
with 2 mM 13-cis-RA for 4 h and then cultured in sterilized sea
water for 0, 2, or 6 h. (A) On the differential display gel, a band
named 2-2 is detectable only in the case of RA-treated cells.
Upregulation is obvious just after a 4-h incubation with RA. (B)
RT-PCR analysis using TRAMP-specific primers. The expression
pattern obtained with the specific primers coincides with that
observed in the differential display analysis.TRAMP mRNA expression during budding was exam-
ined by RT-PCR. TRAMP and glycerin-3-phosphate dehy-
s of reproduction in any form reserved.
41Retinoic Acid-Inducible Protease in AscidiansFIG. 3. The primary structure of TRAMP. (A) TRAMP contains several distinct sequence motifs. Two SRCR domains (1 and 6), three
LDLRA domains (2, 3, and 5), and a plasminogen/plasminogen-related gene B-like (PLMN/PRGB-like) hairpin loop (4) were found. The
N-terminal signal sequence is shown. Arrowheads indicate putative proteolytic cleavage sites. (B) The SRCR domains of TRAMP are
compared with those of other proteases. Bovine ENT, bovine enteropeptidase (SwissProt Accession No. P98072); human MSR, human
macrophage scavenger receptor (P21757); su SpeR, sea urchin Speract receptor (P16264). (C) The LDLRA domains, human LDLR, human
low-density lipoprotein receptor (P01130); Drosophila nudel gene product (P98159). (D) The PLMN/PRGB-like loop, bovine PLMN, bovine
plasminogen (P06868); monkey PLMN, Macaca mulatta plasminogen (P12545); human PRGB, human plasminogen-related gene B product
(Q02325); mouse PLMN, mouse plasminogen (P20918); human PLMN, human plasminogen (P00747). (E) The serine protease catalytic
domain. The sequences conserved among serine proteases belonging to the trypsin family are boxed (Furie et al., 1982). Disulfide bonds are
shown by thick lines. The catalytic triad residues (His, Asp, and Ser) are indicated by asterisks. The residues that occupy the
substrate-binding pocket (Asp, Gly, and Gly) are indicated by arrowheads, human HGFA, human hepatocyte growth factor activator
(Q04756); human UROK, human urokinase-type plasminogen activator (P00749); human ENT, human enteropeptidase (P98073). The
conserved Cys residues that are involved in the disulfide bond formation are indicated by asterisks in (B–E).
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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42 Ohashi et al.drogenase (G3PDH) cDNA fragments were amplified in
single tubes. The PCR products were separated on an
agarose gel and detected by hybridization using
digoxigenin-labeled specific probes. TRAMP mRNA expres-
sion is weak in the buds just after separation from the
parent (Fig. 4A). The amount of TRAMP mRNA gradually
increases up to 36 h (Fig. 4A). In contrast to the TRAMP
FIG. 4. TRAMP mRNA expression during budding. (A) RT-PCR
analysis. RNA was extracted from developing buds 0, 12, 24, and
36 h after separation from the parent. TRAMP and G3PDH cDNA
fragments were amplified by PCR. Compared to the G3PDH signals
(internal control), the TRAMP signal becomes stronger in the later
stages. (B) In situ hybridization using a TRAMP-specific antisense
RNA probe. TRAMP mRNA is detectable exclusively in a mesen-
chymal cell type, called glomerulocytes (arrowheads), in the proxi-
mal region of the developing bud. The epidermis (ep) and atrial
epithelium (ae) are not stained. Brown cells are morula cells that
are also negative. The plane of the photograph is indicated by a red
box in the schematic diagram of the developing bud. See also Fig.
1B.signals, G3PDH signals (internal control) are almost at the
same level in all these samples (Fig. 4A). No signal was
m
(
Copyright © 1999 by Academic Press. All rightetectable in the samples prepared without reverse tran-
criptase (data not shown). These expression patterns are
eproducible when different sets of RNA samples were
sed.
In situ hybridization was attempted to visualize the
ocalization of TRAMP mRNA. Using TRAMP-specific
ntisense RNA probe, hybridization signal was detected in
mesenchymal cell type, called the glomerulocyte, in the
roximal region of the developing bud 3 days after separa-
ion from the parent (Fig. 4B). Hybridization signal was not
etected with a sense RNA probe (data not shown).
The Recombinant TRAMP Catalytic Domain
Shows Trypsin-like Protease Activity and
Stimulates Proliferation of the Cell Line
Derived from the Atrial Epithelium
We produced a GST–TRAMP fusion protein that contains
the TRAMP catalytic domain downstream of the GST. The
affinity-purified GST–TRAMP was examined by SDS–
PAGE (Fig. 5A). The estimated size of the GST–TRAMP on
the gel (about 50 kDa) was consistent with that calculated
from the sequence. The GST–TRAMP cleaved a trypsin-
specific synthetic substrate, Boc-Gln-Ala-Arg-MCA (Fig.
5B). However, a plasmin-specific substrate, Boc-Val-Leu-
Lys-MCA, was not effectively digested by the GST–TRAMP
(Fig. 5B). The cell proliferation promoting activity of the
GST–TRAMP was examined using a cell line derived from
the atrial epithelium (for the cell line see Kawamura and
Fujiwara, 1995b). The cell line does not proliferate in the
tunicate cell culture medium that does not contain fetal
calf serum (Figs. 5C and 5D; Kawamura and Fujiwara,
1995b). The GST–TRAMP stimulated proliferation of the
cell line in a dose-dependent manner (Figs. 5C and 5D). The
proliferation-promoting activity seems to be TRAMP-
specific. The cells exposed to the authentic pancreatic
trypsin formed tight aggregations that were never observed
in case of TRAMP-treated cells (Fig. 5D). The trypsin-
treated cells did not increase in number (Fig. 5D).
DISCUSSION
TRAMP as an RA-Inducible Protease
Two well-known protease genes activated by RA are
apolipoprotein A-I (apoA-I) and tissue-type plasminogen
activator (t-PA). Both belong to the plasminogen subfamily
of the trypsin superfamily and have an N-terminal regula-
tory chain and C-terminal serine protease domain. apoA-I
mRNA expression is stimulated in cultured cynomolgus
hepatocytes after a 4-h incubation with 10 mM RA (Kaptein
t al., 1997). t-PA is induced in human umbilical vein
ndothelial cells (Lansink and Kooistra, 1996). We showed
ere that mRNA expression of a novel modular protease,
amed TRAMP, is activated in the mesenchyme cells of P.
isakiensis after a 4-h treatment with 2 mM RA. The RAR
Hisata et al., 1998), RXR (Kamimura et al. submitted for
s of reproduction in any form reserved.
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43Retinoic Acid-Inducible Protease in Ascidianspublication), and TRAMP (this study) are all expressed in
the glomerulocyte during budding, suggesting the possibil-
ity that TRAMP expression is activated by RAR/RXR
heterodimer in response to RA signal. Although we do not
yet know whether the activation is direct or indirect, this is
the first case of an RA-inducible, developmentally regulated
protease.
Structure and Function of TRAMP
FIG. 5. Biological activity of the recombinant TRAMP catalytic do
loaded with a crude extract of the bacteria containing the GST–TR
GST–TRAMP (p). (B) Trypsin (trp) and plasmin (plm) activities of th
GST–TRAMP showed a trypsin-type substrate specificity. One uni
substrate at 35°C within 1 h. (C) The cell line derived from the at
or various concentrations (80, 160, or 400 units/ml) of the GST–TR
line in a dose-dependent manner. (D) The cell line treated with PB
pancreatic trypsin (1trypsin) for 3 days. The cells treated with the G
aggregates and did not increase in number. The concentration of try
cell line (data not shown).TRAMP has a large, complicated N-terminal chain con-
taining several distinct protein–protein interaction do-
p
k
Copyright © 1999 by Academic Press. All rightains. The SRCR motif, first identified in type-1 macro-
hage scavenger receptor (Resnick et al., 1994), has been
ound in various proteins and is thought to bind other
roteins on the cell surface or extracellular matrix (ECM).
DLRA motif was first found in the ligand-binding domain
f the LDL receptor (Sudhof et al., 1985). The other motif
hat shows similarity to plasminogen and plasminogen-
elated gene B (PLMN/PRGB-like motif) is predicted to
orm a hairpin loop structure by two disulfide bonds. The
. (A) An SDS–PAGE detecting the GST–TRAMP. The left lane was
expression plasmid (c). The right lane was loaded with a purified
T–TRAMP were examined with specific synthetic substrates. The
efined for the enzyme activity that can completely cleave 0.1 mM
pithelium was treated either with phosphate-buffered saline (PBS)
for 4 days. The GST–TRAMP stimulated proliferation of the cell
RAMP), 400 units/ml GST–TRAMP (1TRAMP), or 500 units/ml
RAMP increased in number, but those treated with trypsin formed
ranging from 50 to 500 units/ml had almost the same effect on themain
AMP
e GS
t is d
rial e
AMP
S (2T
ST–Tlasminogen-related gene B (PRGB) product binds to a
ringle domain of plasmin, regulates binding of plasmin to
s of reproduction in any form reserved.
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44 Ohashi et al.fibrin and a2-antiplasmin, and is thought to be involved in
CM degradation (Weissbach and Treadwell, 1992; Ichi-
ose, 1992). Since the catalytic domain of many serine
roteases is cleaved from the N-terminal chain and at-
ached to it by disulfide bonds, the mature TRAMP cata-
ytic domain may associate with its N-terminal chain. The
-terminal chain and its binding proteins may regulate a
rypsin-like protease activity and substrate specificity.
The N-terminal domain may act as an anchor to protect
he TRAMP catalytic domain and other binding proteins
rom diffusion. It is known that serine proteases involved in
lood coagulation circulate in serum as zymogens and that
hey are activated as macromolecular complexes anchored
o the plasma membrane (Furie and Furie, 1988). Protection
rom diffusion must be important if TRAMP acts as a
ocalized signal that induces transdifferentiation of the
trial epithelium at the proximal end of the developing bud.
RAMP protein may assemble other transdifferentiation
actors and anchor them to the ECM or the mesenchyme
ell surface in the proximal region.
It is currently not clear whether the trypsin-like activity
f the TRAMP is required for cell proliferation-promoting
ctivity. However, an authentic trypsin did not stimulate
ell proliferation, suggesting that proteolytic and mitogenic
ctivities are distinct functions of the TRAMP protein.
Role of TRAMP in the Bud Development
Proteases play important roles in various transdifferentia-
tion systems. In general, proteolytic degradation of ECM
destabilizes the differentiated state of epithelial cells and/or
releases growth factors trapped by ECM components. For
example, enzymatic digestion of ECM protein triggers
transdifferentiation of isolated striated muscle cells of a
jellyfish into smooth muscle cells and many other tissue
types (Schmid et al., 1982; Schmid and Alder, 1984).
Kawamura and Watanabe (1987) showed that crude pro-
tease, when injected into the mesenchymal space of the
distal region of the Polyandrocarpa developing bud, in-
duced a complete secondary anteroposterior axis.
TRAMP mRNA is upregulated during bud development.
The recombinant TRAMP catalytic domain stimulated
proliferation of the cell line derived from the atrial epithe-
lium. The cell line has a number of characteristics resem-
bling dedifferentiated atrial epithelium cells (Kawamura
and Fujiwara, 1995b). Considering these results, we propose
that TRAMP stimulates dedifferentiation and/or prolifera-
tion of the atrial epithelium during budding.
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